French-owned pharmaceutical company Egis plans huge investment in Hungary

Egis investment Hungary
Photo: MTI

Hungarian pharmaceutical company Egis will spend HUF 14.5bn on expanding capacity its base in Körmend (Western Hungary).

The investment is supported by a HUF 3.5bn government grant, Minister of Foreign Affairs and Trade Péter Szijjártó said on Monday. Egis today employs 3,800 people in Hungary, the minister said. It spent HUF 20bn on research and development last year and makes over 650 pharmaceutical products in the country.

Szijjártó noted that the government supported 34 major pharmaceutical investments in the past decade with a combined HUF 36bn, helping investors create HUF 240bn worth of investments and thousands of jobs.

Egis investment Hungary
Photo: MTI

Egis said the aim of the investment was to expand production, packaging and warehousing capacity and to upgrade technology.

Egis is a unit of France’s Servier Group. It had revenue of HUF 269.5bn in the business year ended September 30, 2024, public records show.

Read also:

  • Explosion at Egis pharmaceutical factory in Budapest
  • Hungarian pharmacies announce price restrictions

Click for more investment news.

Tags